Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer

N Engl J Med. 2020 Dec 24;383(26):2557-2570. doi: 10.1056/NEJMra1307118.
No abstract available

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant / adverse effects
  • Estrogen Receptor Antagonists / adverse effects
  • Estrogen Receptor Antagonists / therapeutic use*
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Prognosis
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / antagonists & inhibitors*
  • Receptors, Estrogen / metabolism
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / therapeutic use*

Substances

  • Estrogen Receptor Antagonists
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Receptor, ErbB-2